Back to Journals » Infection and Drug Resistance » Volume 1

Successful treatment of a neonate with persistent vancomycin-resistant enterococcal bacteremia with a daptomycin-containing regimen

Authors Christy A Beneri, David P Nicolau, Howard S Seiden, Lorry G Rubin

Published 12 August 2008 Volume 2008:1 Pages 9—11

DOI https://doi.org/10.2147/IDR.S3649

Review by Single-blind

Peer reviewer comments 2

Christy A Beneri1, David P Nicolau2, Howard S Seiden3, Lorry G Rubin1

1Pediatric Infectious Diseases, Schneider Children’s Hospital - North Shore-LIJ Health System, New Hyde Park, New York, USA; 2Center for Anti-Infective Research and Development - Hartford Hospital, Hartford, Connecticut, USA; 3Pediatric Cardiology, Schneider Children’s Hospital - North Shore-LIJ Health System, New Hyde Park, New York, USA

Abstract: Infections caused by vancomycin-resistant enterococci (VRE) may be difficult to treat because of the limited armamentarium of antimicrobial agents. The difficulty is compounded in pediatric patients in general and neonates in particular because many of the newer antimicrobials have not been studied or approved for children. We report a 3-week-old infant who developed enterococcal bacteremia on post-operative day 10 after a surgical palliation for complex congenital heart disease that was complicated by acute renal failure. Despite removal of vascular catheters and antimicrobial regimens that included linezolid, quinupristin/dalfopristin, ampicillin/sulbactam, rifampin, and gentamicin, bacteremia persisted. It was not cleared until daptomycin (in combination with doxycycline) was started. This is the first case of successful treatment of probable endocarditis due to VRE in a neonate using a daptomycin-containing regimen.

Keywords: daptomycin, enterococcus, neonates, pediatrics, endocarditis

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Readers of this article also read:

Corynebacterium urealyticum: a comprehensive review of an understated organism

Salem N, Salem L, Saber S, Ismail G, Bluth MH

Infection and Drug Resistance 2015, 8:129-145

Published Date: 21 May 2015

Moxifloxacin resistance in the F15/LAM4/KZN extensively drug-resistant strain of Mycobacterium tuberculosis

Dookie N, Sturm AW, Moodley P

Infection and Drug Resistance 2014, 7:223-228

Published Date: 19 August 2014

Gold mining areas in Suriname: reservoirs of malaria resistance?

Adhin MR, Labadie-Bracho M, Vreden S

Infection and Drug Resistance 2014, 7:111-116

Published Date: 5 May 2014

Review of oral cholera vaccines: efficacy in young children

Masuet Aumatell C, Ramon Torrell JM, Zuckerman JN

Infection and Drug Resistance 2011, 4:155-160

Published Date: 14 September 2011

Current and novel antibiotics against resistant Gram-positive bacteria

Federico Perez, Robert A Salata, Robert A Bonomo

Infection and Drug Resistance 2008, 1:27-44

Published Date: 9 September 2008